Aperçu rapide pour Early B-Cell Factor 1 (EBF1) (N-Term) Peptide (ABIN976093)
Antigène
EBF1
(Early B-Cell Factor 1 (EBF1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Protein Region
N-Term
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-EBF1 antibody (Catalog #: ARP39578_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
EBF1
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
EBF1
(Early B-Cell Factor 1 (EBF1))
Sujet
TBX22 belongs to the COE family. It contains 1 IPT/TIG domain. TBX22 is a transcriptional activator which recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'.
Alias Symbols: EBF, COE1, OLF1, O/E-1
Protein Interaction Partner: CREBBP,EBF1,PAX5,ZNF423,ZNF521,CREBBP,EBF1,ZNF423